Surgical Oncology Industry Global Overview: Market Size, Growth Insights and Forecast
Report ID : 1368899 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Surgical Oncology Industry is categorized based on Therapeutic Approach (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy) and Application Area (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Gynecological Cancer) and Product Type (Surgical Instruments, Imaging Systems, Biopsy Devices, Radiation Therapy Equipment, Chemotherapy Drugs) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Surgical Oncology Industry, valued at $27 billion in 2023, is anticipated to expand to $45 billion by 2033 at a CAGR of 5.3% from 2024 to 2033. This report covers different segments and offers an analysis of the substantial trends and factors affecting the market.
The introduction of new technology in surgical techniques serves as an impetus for the evolution of the Surgical Oncology market. This further denotes that the market remains surgical procedure-centric while treating Cancer as a whole. Cancer, being one of the highest contributors to human mortality globally, requires highly advanced approaches for the improvement of patient recovery rates. Actually, surgical oncologists leverage multi-disciplinary approaches for complex case management using solid specialized instruments and skill sets.
The last few years have witnessed a surge in the market’s growth due to better detection and treatment options along with increased awareness on cancer, especially within the aging demographic. The development of robotic-assisted surgeries alongside other less invasive techniques has fundamentally changed the field of surgical oncology. These changes promise enriched post-operative experience. As with any other field, there are omnipresent prospects along with difficulties disguised as challenges. We will shed light on the unexplored possibilities and obstacles that foster change in cancer care innovations as we progress into the surgical oncology market.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Medtronic, Johnson & Johnson, Baxter International, Stryker Corporation, Boston Scientific, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., AbbVie Inc., Hologic Inc., Varian Medical Systems, Bristol-Myers Squibb, Siemens Healthineers |
| SEGMENTS COVERED |
By Therapeutic Approach - Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy
By Application Area - Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Gynecological Cancer
By Product Type - Surgical Instruments, Imaging Systems, Biopsy Devices, Radiation Therapy Equipment, Chemotherapy Drugs
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Surgical Oncology Industry Dynamics
The Surgical Oncology Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Surgical Oncology Industry Segmentations
Market Breakup by Therapeutic Approach
- Overview
- Surgery
- Radiation Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
Market Breakup by Application Area
- Overview
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Gynecological Cancer
Market Breakup by Product Type
- Overview
- Surgical Instruments
- Imaging Systems
- Biopsy Devices
- Radiation Therapy Equipment
- Chemotherapy Drugs
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Surgical Oncology Industry
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Medtronic
- Johnson & Johnson
- Baxter International
- Stryker Corporation
- Boston Scientific
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Hologic Inc.
- Varian Medical Systems
- Bristol-Myers Squibb
- Siemens Healthineers
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved